BCL6-IN-5
BCL6-IN-5 is a potent BCL6 inhibitor exacted from patent WO2018215801A1, example 1n, has a pIC50 of 5.82[1].
Product Specifications
CAS Number
2253878-09-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl6-in-5.html
Concentration
10mM
Purity
99.82
Solubility
DMSO : 20.83 mg/mL (ultrasonic)
Smiles
O=C1N(CCC(C)(O)C)C2=CC(NC3=NC(Cl)=NC=C3Cl)=CC=C2N1C
Molecular Formula
C17H19Cl2N5O2
Molecular Weight
396.27
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362-P403+P233-P405-P501
References & Citations
[1]Benjamin Richard BELLENIE, et al. Benzimidazolone derived inhibitors of bcl6. WO2018215801A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA398019 500 µg
Rat IgG (H&L) Antibody ATTO 647N Conjugated Pre-Adsorbed
Sign In for Pricing
View Details 
